Replies to post #559 on Acasti Pharma, Inc (ACST)

[CoolG73]

no worries Mkc, nice run in the last 4 days. was comparing this to the NDA of Vascepa (see the link attached). just for comparison we achieved over 21% mean % change in the 4 g in COLT at 8 weeks , and comparing to Anchor(Page 53,54) ,the maximum mean delta was over 20% ,(and they were all on Statin, while Colt had 30% only on Statin, Omega 3 works better with in given with Statin), so I am really excited about the Trilogy I and II results. seems Capre also is more Potent when you compare the Mean results of Anchor and Colt ( in Anchor the maximum delta was attained at 4 weeks and slid from 20.5% to 17.5% at week 12 while in Colt we jumped from 15% at 4 weeks to 21.5% at 8 weeks, which bodes really well for Trilogy II). GL

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202057Orig1s000MedR.pdf